Device Week – December 2, 2016
Executive Summary
On this week's podcast, we discussed the 21st Century Cures Act, which is headed towards likely enactment this year and includes an array of reforms to streamline the FDA process for medtech. Also, the Trump transition team’s picks for HHS and CMS. Finally, we talked about Edwards Lifesciences' recent acquisition of Valtech Cardio and key imaging industry product launches announced at this year's RSNA meeting.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.